Search Results

There are 7200 results for: content related to: Leuprolide-Induced Myopathy

  1. In vivo evaluation and in vitro metabolism of leuprolide in mice—mass spectrometry-based biomarker measurement for efficacy and toxicity

    Journal of Mass Spectrometry

    Volume 43, Issue 10, October 2008, Pages: 1381–1392, Zacharias D. Sofianos, Theodora Katsila, Nikolaos Kostomitsopoulos, Vaggelis Balafas, John Matsoukas, Theodoros Tselios and Constantin Tamvakopoulos

    Article first published online : 28 APR 2008, DOI: 10.1002/jms.1416

  2. You have free access to this content
    Treatment with leuprolide acetate decreases the threshold of the ventilatory response to carbon dioxide in healthy males

    The Journal of Physiology

    Volume 561, Issue 2, December 2004, Pages: 637–646, Jason H. Mateika, Qasim Omran, J. A. Rowley, X. S. Zhou, M. P. Diamond and M. Safwan Badr

    Article first published online : 26 NOV 2004, DOI: 10.1113/jphysiol.2004.071811

  3. You have free access to this content
    Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study

    BJU International

    Volume 106, Issue 2, July 2010, Pages: 182–187, Fritz H. Schröder, Bertrand Tombal, Kurt Miller, Laurent Boccon-Gibod, Neal D. Shore, E. David Crawford, Judd Moul, Tine Kold Olesen and Bo-Eric Persson

    Article first published online : 13 NOV 2009, DOI: 10.1111/j.1464-410X.2009.08981.x

  4. The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer

    BJU International

    Volume 102, Issue 11, December 2008, Pages: 1531–1538, Laurence Klotz, Laurent Boccon-Gibod, Neal D. Shore, Cal Andreou, Bo-Eric Persson, Per Cantor, Jens-Kristian Jensen, Tine Kold Olesen and Fritz H. Schröder

    Article first published online : 21 NOV 2008, DOI: 10.1111/j.1464-410X.2008.08183.x

  5. Efficacy and safety of androgen deprivation therapy after switching from monthly leuprolide to monthly degarelix in patients with prostate cancer

    International Journal of Clinical Practice

    Volume 65, Issue 5, May 2011, Pages: 559–566, J. de la Rosette, R. Davis III, D. Frankel and T. Kold Olesen

    Article first published online : 22 FEB 2011, DOI: 10.1111/j.1742-1241.2011.02637.x

  6. Characterization and comparison of leuprolide degradation profiles in water and dimethyl sulfoxide

    The Journal of Peptide Research

    Volume 53, Issue 4, April 1999, Pages: 432–441, S.C. Hall, M.M. Tan, J.J. Leonard and C.L. Stevenson

    Article first published online : 15 DEC 2003, DOI: 10.1034/j.1399-3011.1999.00069.x

  7. Effect of agitation regimen on the in vitro release of leuprolide from poly(lactic-co-glycolic) acid microparticles

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 3, March 2012, Pages: 1212–1220, Aurélie Schoubben, Paolo Blasi and Patrick P. Deluca

    Article first published online : 21 DEC 2011, DOI: 10.1002/jps.23029

  8. You have free access to this content
    Gonadotropin-releasing hormone: An update review of the antagonists versus agonists

    International Journal of Urology

    Volume 19, Issue 7, July 2012, Pages: 594–601, Hein Van Poppel and Laurence Klotz

    Article first published online : 14 MAR 2012, DOI: 10.1111/j.1442-2042.2012.02997.x

  9. Comparative efficacy of triptorelin pamoate and leuprolide acetate in men with advanced prostate cancer

    BJU International

    Volume 92, Issue 3, August 2003, Pages: 226–231, C.F. Heyns, M.-P. Simonin, P. Grosgurin, R. Schall, H.C. Porchet and for the South African Triptorelin Study Group

    Article first published online : 23 JUL 2003, DOI: 10.1046/j.1464-410X.2003.04308.x

  10. Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer

    BJU International

    Volume 101, Issue 9, May 2008, Pages: 1096–1100, Yasuhisa Fujii, Junji Yonese, Satoru Kawakami, Shinya Yamamoto, Yuhei Okubo and Iwao Fukui

    Article first published online : 8 JAN 2008, DOI: 10.1111/j.1464-410X.2007.07374.x

  11. Enzymatic stability, solution structure, and antiproliferative effect on prostate cancer cells of leuprolide and new gonadotropin-releasing hormone peptide analogs

    Peptide Science

    Volume 96, Issue 3, 2011, Pages: 260–272, Eleni V. Pappa, Aikaterini A. Zompra, Zinovia Spyranti, Zoi Diamantopoulou, George Pairas, Fotini N. Lamari, Panagiotis Katsoris, Georgios A. Spyroulias and Paul Cordopatis

    Article first published online : 14 JUL 2010, DOI: 10.1002/bip.21521

  12. Evaluation of the pharmacokinetics and pharmacodynamics of two leuprolide acetate 45 mg 6-month depot formulations in patients with prostate cancer

    Clinical Pharmacology in Drug Development

    Volume 3, Issue 4, July/August 2014, Pages: 270–275, Nael M. Mostafa, Kristof Chwalisz, Lois Larsen, Cynthia Mattia-Goldberg, Aaron Spitz and Rajendra S. Pradhan

    Article first published online : 8 MAY 2014, DOI: 10.1002/cpdd.112

  13. Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes

    Intervention Review

    The Cochrane Library

    Demián Glujovsky, Romina Pesce, Gabriel Fiszbajn, Carlos Sueldo, Roger J Hart and Agustín Ciapponi

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD006359.pub2

  14. ORIGINAL ARTICLE: Leuprolide stimulation testing for the evaluation of early female sexual maturation

    Clinical Endocrinology

    Volume 73, Issue 3, September 2010, Pages: 375–381, Anpalakan Sathasivam, Luigi Garibaldi, Sofia Shapiro, James Godbold and Robert Rapaport

    Article first published online : 17 AUG 2010, DOI: 10.1111/j.1365-2265.2010.03796.x

  15. Sustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetate

    Journal of Pharmaceutical Sciences

    Volume 89, Issue 6, June 2000, Pages: 732–741, Harish B. Ravivarapu, Katie L. Moyer and Richard L. Dunn

    Article first published online : 20 JUN 2000, DOI: 10.1002/(SICI)1520-6017(200006)89:6<732::AID-JPS4>3.0.CO;2-D

  16. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology

    Intervention Review

    The Cochrane Library

    Hesham G Al-Inany, Mohamed AFM Youssef, Mohamed Aboulghar, Frank J Broekmans, Monique D. Sterrenburg, Janine G Smit and Ahmed M Abou-Setta

    Published Online : 11 MAY 2011, DOI: 10.1002/14651858.CD001750.pub3

  17. Androgen deprivation therapy: past, present and future

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 1–12, F. Schröder, E.D. Crawford, K. Axcrona, H. Payne and T.E. Keane

    Article first published online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11215.x

  18. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles

    Intervention Review

    The Cochrane Library

    Luiz Eduardo T Albuquerque, Leopoldo O Tso, Humberto Saconato, Maria Cecília R M Albuquerque and Cristiane R Macedo

    Published Online : 31 JAN 2013, DOI: 10.1002/14651858.CD002808.pub3

  19. Follicular mucinosis and mycosis-fungoides-like drug eruption due to leuprolide acetate: a case report and review

    Journal of Cutaneous Pathology

    Volume 39, Issue 11, November 2012, Pages: 1022–1025, Sara C. Shalin, Julie Brantley and A. Hafeez Diwan

    Article first published online : 10 AUG 2012, DOI: 10.1111/j.1600-0560.2012.01980.x

  20. Effect of additives on release profile of leuprolide acetate in an in situ forming controlled-release system: In vitro study

    Journal of Applied Polymer Science

    Volume 107, Issue 6, 15 March 2008, Pages: 3781–3787, M. Zare, H. Mobedi, J. Barzin, H. Mivehchi, A. Jamshidi and R. Mashayekhi

    Article first published online : 6 DEC 2007, DOI: 10.1002/app.27520